Improving Profitability through Greater Price Competitiveness and Cost Reduction
First written in FY2018-Q3. 21 of 22 entries say "Restated". Latest entry: 2026-09-30.
No other company in this theme has enough history to compare yet.
- FY2026-H1RestatedAnnual report
「In the healthcare industry, while demand for healthcare services continues to rise, medical institutions remain in an extremely difficult operating environment because of higher material and utility costs, labor shortages and higher personnel expenses resulting from revisions to working arrangements in the medical field.」
Medical institutions continue to face a difficult operating environment because of higher material and utility costs, labor shortages, and rising personnel expenses, creating ongoing pressure to improve profitability. - FY2024-Q2RestatedAnnual report
「Meanwhile, the basic policy for the fiscal 2024 medical fee revision has been presented, addressing economic and social conditions such as higher prices and wages and the need to secure medical and long-term care personnel.」
The environment surrounding profitability remains challenging, with higher prices and wages and the fiscal 2024 medical fee revision continuing to be highlighted. - FY2024-Q1RestatedAnnual report
「Meanwhile, medical operating expenses are trending higher because of the sharp rise in prices and energy costs and the need to secure funding for wage increases, while discussions have begun on formulating the basic policy for the next revision of medical service fees in fiscal 2024. As medical institutions continue to face difficult operating conditions, measures to secure a stable healthcare delivery system are required.」
Medical institutions continue to face higher costs due to prices, energy expenses, and wage increases, while discussions have begun on the fiscal 2024 medical fee revision. - FY2023RestatedAnnual report
「In the medical equipment industry, medical institutions and others are experiencing a significant impact on their operations because they cannot pass higher costs on to prices amid rising resource and raw-material prices. As demands from medical institutions and others seeking to improve their management for lower delivered prices remain severe, companies are increasingly required to contribute to higher medical operating revenue by providing products and services that improve medical institutions' management and efficiency.」
Amid higher resource and raw-material prices and continued demands from medical institutions for lower delivered prices, companies remain under pressure to improve their profitability and support medical institutions' management. - FY2023-Q3RestatedAnnual report
「In the medical equipment industry, as adverse factors such as lower reimbursement prices for medical materials following the medical fee revision and higher resource and raw-material prices increase, companies are increasingly required not only to provide products and services that meet medical institutions' needs and support management improvement and operational efficiency, but also to contribute to higher medical operating revenue through cost reductions.」
The industry continues to require contributions to medical operating revenue through products, services, and cost reductions amid lower reimbursement prices and higher resource and raw-material prices. - FY2023-Q2RestatedAnnual report
「In the medical equipment industry, as adverse factors such as lower reimbursement prices for medical materials following the medical fee revision and higher resource and raw-material prices increase, companies are increasingly required not only to provide products and services that meet medical institutions' needs and support management improvement and operational efficiency, but also to contribute to higher medical operating revenue through cost reductions.」
As lower medical material prices and higher resource and raw-material prices persist, the industry continues to demand contributions to medical institutions' revenue improvement through products, services, and cost reductions. - FY2023-Q1RestatedAnnual report
「In the medical equipment industry, as adverse factors such as lower reimbursement prices for medical materials following the medical fee revision and higher resource and raw-material prices increase, companies are increasingly required not only to provide products and services that meet medical institutions' needs and support management improvement and operational efficiency, but also to contribute to higher medical operating revenue through cost reductions.」
As lower medical material prices and higher resource and raw-material prices worsen the environment, companies are increasingly expected to contribute to higher medical operating revenue through products, services, and cost reductions. - FY2022-Q1RestatedAnnual report
「In the medical equipment industry, as the COVID-19 pandemic has had a significant impact on the operating environment for medical institutions, companies are increasingly required to have the ability to propose services that meet medical institutions' needs and help improve their management, as well as to improve profitability through price competitiveness and cost reductions. Competition among companies is expected to intensify further.」
The continuing need for proposal capabilities, price competitiveness, and improved profitability through cost reductions has been reaffirmed amid the difficult operating environment for medical institutions during COVID-19. - FY2021-Q3RestatedAnnual report
「In the medical equipment industry, as the operating environment for medical institutions has become extremely challenging because of the COVID-19 pandemic, companies are increasingly required to have the ability to propose services that help medical institutions improve their management, as well as to improve profitability through price competitiveness and cost reductions, and competition among companies is intensifying further.」
As medical institutions face a difficult operating environment during COVID-19, demand continues for service-proposal capabilities, price competitiveness, and improved profitability through cost reductions. - FY2021-Q1RestatedAnnual report
「Companies are increasingly required to have the ability to propose services that help medical institutions improve their management during the COVID-19 pandemic, as well as to improve profitability through price competitiveness and cost reductions, and competition among companies is intensifying further.」
The context of supporting medical institutions' management during COVID-19 has been added, while the continuing challenges of improving profitability through price competitiveness, cost reductions, and proposal capabilities remain. - FY2020RestatedAnnual report
「Companies are increasingly required to have the ability to propose services that help medical institutions improve their management, as well as to improve profitability through price competitiveness and cost reductions, and competition among companies is intensifying further.」
Improving profitability through price competitiveness, cost reductions, and proposal capabilities continues to be identified as a challenge in responding to industry conditions. - FY2020-Q3RestatedAnnual report
「Against this backdrop, companies are increasingly required to have the ability to propose services that help medical institutions improve their management, as well as to improve profitability through price competitiveness and cost reductions, and competition among companies is intensifying further.」
The need to strengthen price competitiveness, improve profitability through cost reductions, and enhance proposal capabilities for medical institutions continues to be highlighted. - FY2020-Q2RestatedAnnual report
「Against this backdrop, companies are required not only to further strengthen price competitiveness and improve profitability through cost reductions, but also to enhance their ability to respond to proposals that help medical institutions improve their management.」
The need to strengthen price competitiveness, improve profitability through cost reductions, and improve responsiveness to proposals that support medical institutions' management continues. - FY2020-Q1RestatedAnnual report
「The medical equipment industry is seeing greater demand for proposals that help medical institutions improve their management. Companies are therefore required to further strengthen price competitiveness, improve profitability through cost reductions, and enhance their ability to respond to customer needs.」
Strengthening price competitiveness, improving profitability through cost reductions, and enhancing responsiveness to customer needs continue to be required. - FY2019RestatedAnnual report
「While maintaining high-quality services for customers, we will seek to improve profitability by creating a structural transformation that enables all Group employees to remain conscious of profitability and steadily and continuously generate earnings.」
The policy of improving profitability through greater awareness of profitability among all employees, structural transformation, and stronger planning and product-proposal capabilities has been reaffirmed. - FY2019-Q3RestatedAnnual report
「Competition among companies is intensifying further, with demand increasing not only for the ability to propose services that help medical institutions improve their management, but also for greater price competitiveness and improved profitability through cost reductions.」
In addition to service-proposal capabilities, strengthening price competitiveness and improving profitability through cost reductions continue to be identified as industry challenges. - FY2019-Q1RestatedAnnual report
「In the medical equipment industry, as the operating environment for regional medical institutions changes, competition among companies is intensifying further, partly because of the impact of lower selling prices for medical materials following the medical fee revision in April this year. Improving price competitiveness and profitability through cost reductions is therefore a key challenge.」
The need to improve price competitiveness and profitability through cost reductions has been reaffirmed as a response to lower selling prices and intensifying competition following the medical fee revision. - FY2018RestatedAnnual report
「The business environment now requires further enhancement of price competitiveness and improved profitability through cost reductions in response to demands for lower selling prices of medical materials following revisions to medical service fees.」
Improving price competitiveness and profitability through cost reductions continues to be identified as a challenge in responding to industry conditions. - FY2018-Q3First statedAnnual report
「The business environment now requires further enhancement of price competitiveness and improved profitability through cost reductions.」
This is identified as a challenge and objective in responding to competition in the medical equipment industry.